Optimal interval for routine cytologic screening in the United States.

Hans-Georg Eichler, Sheldon X. Kong, William C. Gerth, Panagiotis Mavros, Bengt Jönsson, Use of Cost‐Effectiveness Analysis in Health‐Care Resource Allocation Decision‐Making: How Are Cost‐Effectiveness Thresholds Expected to Emerge? Value in Health. ,vol. 7, pp. 518- 528 ,(2004) , 10.1111/J.1524-4733.2004.75003.X

Katherine B. Roland, Ashwini Soman, Vicki B. Benard, Mona Saraiya, Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States American Journal of Obstetrics and Gynecology. ,vol. 205, pp. 447- ,(2011) , 10.1016/J.AJOG.2011.06.001

Andrea R. Spence, Patricia Goggin, Eduardo L. Franco, Process of care failures in invasive cervical cancer: systematic review and meta-analysis. Preventive Medicine. ,vol. 45, pp. 93- 106 ,(2007) , 10.1016/J.YPMED.2007.06.007

Debbie Saslow, Diane Solomon, Herschel W. Lawson, Maureen Killackey, Shalini L. Kulasingam, Joanna M. Cain, Francisco A. R. Garcia, Ann T. Moriarty, Alan G. Waxman, David C. Wilbur, Nicolas Wentzensen, Levi S. Downs, Mark Spitzer, Anna-Barbara Moscicki, Eduardo L. Franco, Mark H. Stoler, Mark Schiffman, Philip E. Castle, Evan R. Myers, American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer Journal of Lower Genital Tract Disease. ,vol. 16, pp. 175- 204 ,(2012) , 10.1097/LGT.0B013E31824CA9D5

Virginia A Moyer, US Preventive Services Task Force*, None, Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement Annals of Internal Medicine. ,vol. 156, pp. 880- 891 ,(2012) , 10.7326/0003-4819-156-12-201206190-00424